News | October 04, 2024
Lilly invests US$ 4.5 billion to create advanced research and manufacturing site
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Enzalutamide Tablets will be produced at the Group’s manufacturing site at SEZ, Ahmedabad
Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression
Enzalutamide Capsules will be produced at the Group’s manufacturing site at Moraiya, Ahmedabad
India has taken the lead in recognising NAFLD as a major non-communicable disease
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Subscribe To Our Newsletter & Stay Updated
